The historic rise of Viagra has consistently remained a example of pharmaceutical success, however its legacy within the broader sector now raises questions about potential yields . Copycat versions are diminishing exclusivity , causing concerns that betting on companies significantly dependent to Viagra's former position could be a problematic mov